X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tapentadol (106) 106
index medicus (99) 99
humans (77) 77
pain (61) 61
analgesics (52) 52
double-blind (51) 51
male (47) 47
pharmacology & pharmacy (45) 45
female (40) 40
efficacy (39) 39
hydrochloride (37) 37
phenols - therapeutic use (37) 37
opioid receptor agonist (35) 35
animals (34) 34
care and treatment (34) 34
opioids (33) 33
phenols - administration & dosage (32) 32
narcotics (31) 31
pain - drug therapy (31) 31
analgesics, opioid - therapeutic use (30) 30
chronic pain (30) 30
clinical neurology (29) 29
middle aged (29) 29
tapentadol hydrochloride (29) 29
anesthesiology (28) 28
tolerability (28) 28
tramadol (28) 28
oxycodone (26) 26
medicine & public health (24) 24
morphine (24) 24
adult (23) 23
aged (23) 23
extended-release (23) 23
phase-iii (23) 23
receptors, opioid, mu - agonists (23) 23
analgesics, opioid - administration & dosage (22) 22
analgesics, opioid - adverse effects (22) 22
management (22) 22
opioid (22) 22
reuptake inhibitor (22) 22
analysis (21) 21
phenols - pharmacology (21) 21
phenols - adverse effects (20) 20
immediate-release (19) 19
internal medicine (19) 19
neuropathic pain (19) 19
analgesics, opioid - pharmacology (18) 18
osteoarthritis (18) 18
low-back-pain (17) 17
neurosciences (17) 17
dose-response relationship, drug (16) 16
double-blind method (16) 16
oxycodone ir (16) 16
pain management (16) 16
pharmacokinetics (16) 16
placebo (16) 16
analgesia (15) 15
pain measurement (15) 15
pharmacology/toxicology (15) 15
treatment outcome (15) 15
chronic noncancer pain (14) 14
chronic pain - drug therapy (14) 14
drug therapy (14) 14
medicine (14) 14
safety (14) 14
medicine, general & internal (13) 13
medicine, research & experimental (13) 13
metabolites (13) 13
acute pain (12) 12
analgesics - therapeutic use (12) 12
quality of life (12) 12
young adult (12) 12
hcl (11) 11
neuralgia - drug therapy (11) 11
oxycodone - administration & dosage (11) 11
oxycodone - adverse effects (11) 11
pain medicine (11) 11
phenols - pharmacokinetics (11) 11
175591-09-0 (10) 10
analgesics - administration & dosage (10) 10
arthritis (10) 10
constipation (10) 10
drug dosages (10) 10
low back pain - drug therapy (10) 10
oncology (10) 10
original research (10) 10
research (10) 10
175591-23-8 (9) 9
cancer pain (9) 9
delayed-action preparations (9) 9
noradrenaline (9) 9
pain - etiology (9) 9
veterinary sciences (9) 9
aged, 80 and over (8) 8
analgesics, opioid - pharmacokinetics (8) 8
back-pain (8) 8
clinical trials (8) 8
clinical trials as topic (8) 8
comparative analysis (8) 8
controlled phase-iii (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2011, Volume 19, Issue 3, pp. 1136 - 1154
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 06/2018, Volume 48, Issue 6, pp. 542 - 547
The non-inferiority of hydromorphone compared with oxycodone for the treatment of cancer pain was confirmed in 183 Japanese cancer patients. Hydromorphone and... 
Hydromorphone | Cancer pain | Palliative medicine | Oxycodone | Double-blind study | cancer pain | hydromorphone | MANAGEMENT | ONCOLOGY | RECOMMENDATIONS | TAPENTADOL | palliative medicine | GUIDELINES | oxycodone | double-blind study | EAPC
Journal Article
Advances in Therapy, ISSN 0741-238X, 5/2011, Volume 28, Issue 5, pp. 401 - 417
Journal Article
American journal of veterinary research, ISSN 0002-9645, 04/2018, Volume 79, Issue 4, pp. 367 - 375
OBJECTIVE To evaluate pharmacokinetic and pharmacodynamic characteristics of 3 doses of tapentadol hydrochloride orally administered in dogs. ANIMALS 6 healthy... 
HCL | TRAMADOL | METABOLISM | MULTIMODAL PAIN MANAGEMENT | OPIOID RECEPTOR AGONIST | VETERINARY SCIENCES | REUPTAKE INHIBITOR
Journal Article
Journal of Molecular Structure, ISSN 0022-2860, 11/2015, Volume 1100, pp. 188 - 202
Tapentadol is a novel opioid pain reliever drug with a dual mechanism of action, having potency between morphine and tramadol. Quantum chemical calculations... 
FT-IR | DFT | Tapentadol hydrochloride | FT-NMR | FT-Raman | SOLAR-CELLS | SUBSTITUTED BENZENES | AB-INITIO | OPIOID RECEPTOR AGONIST | CHEMISTRY, PHYSICAL | INFRARED-SPECTRA | MODES | MOLECULAR-STRUCTURES | CONFORMATIONAL-ANALYSIS | VIBRATIONAL ASSIGNMENT | Morphine | Raman spectroscopy | Hardness | Analysis | Methods
Journal Article
International Journal of Chemical and Analytical Science, ISSN 0976-1209, 06/2013, Volume 4, Issue 2, pp. 67 - 72
To develop a simple, novel, sensitive, precise and specific RP-HPLC method for the determination of Tapentadol hydrochloride in bulk and its tablet dosage... 
Isocratic mode | Tapentadol hydrochloride | Licrosphere column | Methanol | Quantitative analysis
Journal Article
Journal of Analytical Science and Technology, ISSN 2093-3371, 12/2013, Volume 4, Issue 1, pp. 1 - 7
Tapentadol is a novel centrally acting analgesic. There is no method for the determination of drug content in dosage form without any interference of any... 
RP-HPLC | Chemistry | Analytical Chemistry | Characterization and Evaluation of Materials | Tablet | Tapentadol hydrochloride | Environmental Monitoring/Analysis
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 07/2013, Volume 22, Issue 14, pp. 1691 - 1693
Journal Article
Advances in Therapy, ISSN 0741-238X, 6/2010, Volume 27, Issue 6, pp. 381 - 399
This pooled analysis of data from three phase 3 studies in patients with chronic osteoarthritis knee or low back pain evaluated the efficacy and tolerability... 
oxycodone controlled release | EQ-5D | chronic pain | treatment discontinuation | low back pain | osteoarthritis | Rheumatology | Oncology | Internal Medicine | opioid responder rates | SF-36 | Medicine & Public Health | opioid tolerability | Pharmacology/Toxicology | Cardiology | quality of life | Endocrinology | tapentadol prolonged release | Opioid responder rates | Oxycodone controlled release | Treatment discontinuation | Low back pain | Opioid tolerability | Chronic pain; EQ-5D | Osteoarthritis | Tapentadol prolonged release | Quality of life | OXYCODONE | MEDICINE, RESEARCH & EXPERIMENTAL | MODERATE | NONCANCER PAIN | OPIOID RECEPTOR AGONIST | HYDROCHLORIDE | TABLETS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | OXYMORPHONE EXTENDED-RELEASE | Humans | Middle Aged | Male | Osteoarthritis, Knee - psychology | Clinical Trials, Phase III as Topic | Low Back Pain - psychology | Female | Quality of Life - psychology | Safety | Phenols - pharmacology | Severity of Illness Index | Oxycodone - therapeutic use | Double-Blind Method | Osteoarthritis, Knee - diagnosis | Kaplan-Meier Estimate | Analgesics, Opioid - therapeutic use | Treatment Outcome | Low Back Pain - diagnosis | Randomized Controlled Trials as Topic | Low Back Pain - drug therapy | Analysis of Variance | Phenols - therapeutic use | Least-Squares Analysis | Aged | Pain Measurement | Chronic Disease | Delayed-Action Preparations | Osteoarthritis, Knee - drug therapy | Care and treatment | Pain | Oxycodone | Analysis | Backache | Chronic pain
Journal Article